?

當(dāng)前位置:標(biāo)準(zhǔn)品 > 菌種購買 > 細(xì)胞 >
人非小細(xì)胞肺癌細(xì)胞NCI-H1650
??【編號(hào)】:NCI-H1650

??【名稱】:人非小細(xì)胞肺癌細(xì)胞NCI-H1650

??【規(guī)格】:株

??【價(jià)格】:1800

  人非小細(xì)胞肺癌細(xì)胞

  細(xì)胞名稱:NCI-H1650人非小細(xì)胞肺癌細(xì)胞
  描述:這株細(xì)胞建于1987年五月。患者吸煙。 每年10包。
  動(dòng)物種別:人
  性別:男
  組織來源:肺;腺癌;細(xì)支氣管及肺泡癌;轉(zhuǎn)移灶;胸水
  形態(tài):上皮細(xì)胞樣
  培養(yǎng)基和添加劑:RPMI-1640(GIBCO,貨號(hào)31800022, 添加NaHCO3 1.5g/L, glucose 2.5g/L, Sodium Pyruvate 0.11g/L),90%;優(yōu)質(zhì)胎牛血清,10%。 氣相:空氣,95%;二氧化碳,5%。 溫度:37攝氏度。
  供應(yīng)限制:A。僅供研究之用。
  REFERENCE:NCI-Navy Medical Oncology Branch Cell Line Supplement. J. Cell. Biochem. suppl. 24: 1996. Sordella R , et al. Gefitinib-sensitizing EGFR mutations in lung cancer activate anti-apoptotic pathways. Science 305: 1163-1167, 2004. PubMed: 15284455 Hay, R. J., Caputo, J. L., and Macy, M. L., Eds. (1992), ATCC Quality Control Methods for Cell Lines. 2nd edition, Published by ATCC. Caputo, J. L., Biosafety procedures in cell culture. J. Tissue Culture Methods 11:223-227, 1988. Fleming, D.O., Richardson, J. H., Tulis, J.J. and Vesley, D., (1995) Laboratory Safety: Principles and Practice. Second edition, ASM press, Washington, DC. Centers for Disease Control (1993), Biosafety in Microbiological and Biomedical Laboratories Human Health Service Publication No. (CDC) 93-8395. U.S. Dept. of Health and Human Services; 3rd Edition U.S. Government Printing Office Washington D.C.
上一篇:人肺腺癌細(xì)胞NCI-H1395 下一篇:人經(jīng)典小細(xì)胞肺癌細(xì)胞NCI-H1688



    ?
    首 頁 | 對(duì)照品| 標(biāo)準(zhǔn)品| 標(biāo)準(zhǔn)物質(zhì)| 實(shí)驗(yàn)試劑| 培養(yǎng)基| 菌種購買| 新聞中心| 聯(lián)系我們| 網(wǎng)站地圖

    2011-2018 中檢計(jì)量-萊耀生物@版權(quán)所有

    ?